We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » IMS Says Patent Settlements Saved $25.5 Billion Since 2005
IMS Says Patent Settlements Saved $25.5 Billion Since 2005
July 16, 2013
Patent settlements between brand and generic drugmakers are not anticompetitive, and in fact are “procompetitive and proconsumer,” Ralph Neas, president and CEO of GPhA, said July 9, adding that an IMS Institute for Healthcare Informatics report released the same day proves just that.